IN2014DN08407A - - Google Patents

Info

Publication number
IN2014DN08407A
IN2014DN08407A IN8407DEN2014A IN2014DN08407A IN 2014DN08407 A IN2014DN08407 A IN 2014DN08407A IN 8407DEN2014 A IN8407DEN2014 A IN 8407DEN2014A IN 2014DN08407 A IN2014DN08407 A IN 2014DN08407A
Authority
IN
India
Prior art keywords
methods
compositions
immunostimulatory cell
cell compositions
activated immunostimulatory
Prior art date
Application number
Other languages
English (en)
Inventor
Irene Ginis
Alan Smith
Marina Bubis
Mitchell Shirvan
Original Assignee
Macrocure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrocure Ltd filed Critical Macrocure Ltd
Publication of IN2014DN08407A publication Critical patent/IN2014DN08407A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN8407DEN2014 2012-03-15 2013-03-13 IN2014DN08407A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261611180P 2012-03-15 2012-03-15
PCT/IB2013/000935 WO2013136191A1 (en) 2012-03-15 2013-03-13 Activated immunostimulatory cell composition for therapy of infection

Publications (1)

Publication Number Publication Date
IN2014DN08407A true IN2014DN08407A (enExample) 2015-05-08

Family

ID=48483110

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8407DEN2014 IN2014DN08407A (enExample) 2012-03-15 2013-03-13

Country Status (8)

Country Link
US (1) US20150071892A1 (enExample)
EP (1) EP2825182A1 (enExample)
JP (1) JP2015509974A (enExample)
CA (1) CA2864838A1 (enExample)
IN (1) IN2014DN08407A (enExample)
MX (1) MX2014010893A (enExample)
RU (1) RU2014140795A (enExample)
WO (1) WO2013136191A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2810629A1 (en) 2010-09-09 2012-03-15 Macrocure, Ltd. Activated leukocyte conditioned supernatant and uses for wound healing
CA3037882A1 (en) * 2016-09-23 2018-03-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
CN111065400A (zh) * 2017-10-03 2020-04-24 公益财团法人东京都医学总合研究所 抗流感药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7713739B1 (en) 2000-11-17 2010-05-11 Novartis Vaccines And Diagnostics, Inc. Microparticle-based transfection and activation of dendritic cells
KR101131727B1 (ko) 2004-06-11 2012-03-28 가톨릭대학교 산학협력단 ＣＥＡ-특이적인 세포독성 Ｔ세포를 생성하는 재조합 아데노바이러스 ＡｄＶＣＥＡ로 트랜스덕션된 수지상세포, 이를 포함하는 백신 및 약제학적 조성물
EP1748067A1 (en) 2005-07-29 2007-01-31 Institut Pasteur Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
MX2011009277A (es) 2009-03-05 2011-12-16 Macrocure Ltd Composicion de leucocito activada.

Also Published As

Publication number Publication date
EP2825182A1 (en) 2015-01-21
MX2014010893A (es) 2015-06-23
CA2864838A1 (en) 2013-09-19
RU2014140795A (ru) 2016-05-10
WO2013136191A1 (en) 2013-09-19
US20150071892A1 (en) 2015-03-12
JP2015509974A (ja) 2015-04-02

Similar Documents

Publication Publication Date Title
IN2015DN02826A (enExample)
TN2012000414A1 (en) Forms of rifaximin and uses thereof
IN2014CN04251A (enExample)
PT2750682T (pt) Composição compreendendo a flora intestinal cultivada anaerobiamente
NZ629697A (en) Human anti-cd27 antibodies, methods and uses
EA201391611A1 (ru) Вызывающие иммунную толерантность синтетические наноносители для терапевтического лечения аллергии
EA201300585A1 (ru) Иммуномодулирующие олигонуклеотиды
MX2016008448A (es) Conjugados de var2csa-farmaco.
ZA201307394B (en) Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
IN2014DN11201A (enExample)
MY185016A (en) Progenitor cells of mesodermal lineage
MX385845B (es) Usos y composiciones de la flagelina
IN2014DN06104A (enExample)
ZA201500099B (en) Radiation-curable ,stable nail gel compositions and methods of preparation and use
EP3046588A4 (en) Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
EA201500054A1 (ru) Аттенуированные вакцины против streptococcus suis и способы их получения и применения
EP3610887B8 (en) Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
ZA201903574B (en) Methods of using human mesenchymal stem cells to effect cellular and humoral immunity
EA201401117A1 (ru) Композиции, содержащие пробиотики и комплекс пчелиной пыльцы/глины, способ их приготовления и их применение в питании и терапии
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
EP2849772A4 (en) TUMOR VACCINES TREATED AGAINST CANCER STEM CELLS
IN2014DN08407A (enExample)
IN2014DN08093A (enExample)
MX2013014420A (es) Composiciones en gel.
AU346524S (en) Spacer